Torrent Pharmaceuticals to acquire Curatio Healthcare

1 Oct 2022 , 01:35 AM

Torrent Pharmaceuticals has entered into definitive agreements to acquire 100Percentage of Curatio Healthcare I Curatio for Rs 2000 crore The consideration includes Rs 115 crore on the date of signing of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs 1885 crore Curatio has a strong presence in the cosmetic dermatology segment with a portfolio of over 50 brands marketed in India Curatios portfolio consists of leading brands such as Tedibar Atogla Spoo B4 Nappi and Permite which are ranked amongst top 5 brands in their covered market Top ten brands of Curatio account for ~75Percentage of total revenue With this acquisition Torrent Pharma will add a Field Force of 600 MRs and a distribution network of 900 stockists Curatios reported revenue for FY21-22 was Rs 224 Crores With YTD August sales up 25Percentage Curatio is expected to cross Rs 275 crores revenue in FY23 Dermatology accounts for 82Percentage of Curatios revenue Within dermatology cosmetic dermatology is a leading contributor Over the last decade cosmetic dermatology as a therapy has delivered an 18Percentage CAGR which is 16x of the IPM CAGR With this deal Torrent Pharma will enter the league of top 10 players in the dermatology segment and will be the leader in the cosmetic dermatology space